Brain Atrophy, Serum NfL Levels May Predict Cognition Early in MS

Brain Atrophy, Serum NfL Levels May Predict Cognition Early in MS

305119

Brain Atrophy, Serum NfL Levels May Predict Cognition Early in MS

A blood test for serum neurofilament light chain (sNfL) levels, along with radiological findings, can help to detect early cognitive issues in people recently diagnosed with multiple sclerosis (MS), a study suggests. The study “Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis,” published in the journal Neurology: Neuroimmunology and Neuroinflammation, focused on the use of sNfL levels — when combined with MRI findings — as a way to…

You must be logged in to read/download the full post.